Omega-3 polyunsaturated fatty acids/turmeric Interactions
There are 141 drugs known to interact with omega-3 polyunsaturated fatty acids/turmeric, along with 2 disease interactions. Of the total drug interactions, 141 are moderate.
- View all 141 medications that may interact with omega-3 polyunsaturated fatty acids/turmeric
- View omega-3 polyunsaturated fatty acids/turmeric disease interactions (2)
Most frequently checked interactions
View interaction reports for omega-3 polyunsaturated fatty acids / turmeric and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Armour Thyroid (thyroid desiccated)
- Benadryl (diphenhydramine)
- Calcium Stool Softener (docusate)
- Eliquis (apixaban)
- Excedrin Migraine (acetaminophen / aspirin / caffeine)
- Farxiga (dapagliflozin)
- Flax Seed Oil (flax)
- Ginger Root (ginger)
- Glucosamine & Chondroitin with MSM (chondroitin / glucosamine / methylsulfonylmethane)
- Iron Sulfate (ferrous sulfate)
- Melatonin Time Release (melatonin)
- Metoprolol Tartrate (metoprolol)
- MiraLAX (polyethylene glycol 3350)
- Mobic (meloxicam)
- Naproxen Sodium DS (naproxen)
- Nature's Bounty Probiotic (bifidobacterium infantis / lactobacillus acidophilus)
- Omega-3 (omega-3 polyunsaturated fatty acids)
- Ozempic (semaglutide)
- Penicillin VK (penicillin v potassium)
- Percocet (acetaminophen / oxycodone)
- Probiotic Formula (bifidobacterium infantis / lactobacillus acidophilus)
- Super B Complex (multivitamin)
- Synthroid (levothyroxine)
- Tylenol (acetaminophen)
- Ubrelvy (ubrogepant)
- Vitamin B1 (thiamine)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
Omega-3 polyunsaturated fatty acids/turmeric disease interactions
There are 2 disease interactions with omega-3 polyunsaturated fatty acids / turmeric which include:
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.